Macro Insights - October CPI turned positive year-on-year, exceeding market expectations, driven by the weakening high base effect, seasonal food price increases, holiday effects, and medical price reforms impacting service prices [2] - PPI recorded its first month-on-month increase this year, attributed to improved supply-demand dynamics in industrial products and rising international metal prices [2] Trade Data - In October 2025, China's exports fell by 1.1% year-on-year, significantly down from the previous month, primarily due to high base effects. Integrated circuits and automobiles were key export drivers, while labor-intensive products contributed negatively [3] - The export growth rate is expected to remain affected by high base effects in the remaining months of the year, but supportive non-US economies and easing US-China trade relations are likely to maintain a favorable export outlook [3] Market Strategy - The current market position is seen as a potential starting point for a long-term bull market, with gradual improvements in fundamentals and industry highlights as the foundation. The inflow of resident funds and policy support will influence market trends [4][10] - The market may enter a wide-ranging consolidation phase in the short term, with a focus on defensive and consumer sectors, while mid-term attention remains on TMT and advanced manufacturing sectors [10] Bond Market - The secondary market for REITs showed a downward trend, with the weighted REITs index closing at 182.3, reflecting a return rate of -0.48% for the week [5] - Credit bond issuance totaled 334 bonds with a total scale of 363.4 billion yuan, a decrease of 7.66% week-on-week, while industrial bonds saw a 5.36% increase in issuance [6] Industry Research TMT Sector - The narrative around AI investments is shifting from "need to invest" to "need for returns," leading to a revaluation of AI visibility and realization. Major tech companies are experiencing accelerated growth in cloud computing revenue, validating AI demand [11] - Recommended stocks include Microsoft, with a focus on Google, Amazon, and Meta [11] Basic Chemicals - Strong demand for energy storage is tightening the supply-demand situation for iron phosphate, leading to improved prices and profitability for leading phosphate chemical companies [12] - Suggested stocks include Yuntianhua, Chuanheng, and Xingfa Group [12] Oil and Gas - OPEC+ announced a pause in production increases, which is expected to alleviate concerns over oil supply. Geopolitical tensions are likely to support oil prices [13] - The report highlights risks related to upstream capital expenditure growth and price volatility [13] Food and Beverage - Recommendations include strong brands with high dividend returns like Kweichow Moutai and Shanxi Fenjiu, as well as companies benefiting from structural upgrades in the beer sector [14] - Suggested stocks include Yihai International and Mengniu Dairy [14] Automotive - The automotive market showed strong performance in October, with NIO's monthly sales surpassing 40,000 units. Recommended stocks include NIO and XPeng Motors [15] - Suggested components include Fuyao Glass and Wuxi Zhenhua [15] Textile and Apparel - The textile and apparel sector is focusing on mitigating tariff impacts and enhancing market share among leading companies. Recommended stocks include Shenzhou International and Anta Sports [16] - The cosmetics sector is expected to highlight the capabilities of leading companies amid intensified competition [16] Company Research Hong Kong Stock Exchange - The company reported record high revenue and profit for the first three quarters of 2025, driven by active trading in the Hong Kong stock market [17] - The forecast for net profit from 2025 to 2027 is 17.3 billion, 18.5 billion, and 19.5 billion HKD, maintaining a "buy" rating [17] Farah Electronics - The company achieved a revenue of 1.445 billion yuan in Q3 2025, with a year-on-year growth of 9.31%. The market share in the new energy sector continues to rise [18] - The stock is rated as a "buy" with a projected PE of 20X, 16X, and 14X for 2025-2027 [18] Huahong Semiconductor - The company is entering a price increase cycle due to sustained demand recovery, with adjusted net profit forecasts for 2025-2027 of 70 million, 150 million, and 190 million USD [19] - The stock is rated as a "buy" based on market share growth and long-term revenue potential [19] Meili Tianyuan Medical Health - The acquisition of Siyanli is expected to enhance the company's performance, with revised net profit forecasts for 2025-2027 of 320 million, 440 million, and 490 million yuan [20] - The stock is rated as a "buy" with a focus on shareholder returns [20]

1. Report Industry Investment Rating - The industry rating is "Bullish" [1] 2. Core Views of the Report - The cosmetics industry continues to show differentiation, with brand demand being weak in the off - season, agents seeking change in difficult situations, and producers seizing supply - chain reconstruction opportunities. The medical aesthetics industry has new entrants with better - than - expected shipments, and new product catalysts are worth attention [3][4] 3. Summaries According to Relevant Catalogs 3.1 Cosmetics: Continued Differentiation 3.1.1 Brand Merchants - In 1 - 3Q25, beauty brand merchants' revenue was 28.4 billion yuan, a year - on - year decrease of 0.6%; personal care brand merchants' revenue was 5.7 billion yuan, a year - on - year increase of 12.4%. In 3Q25, beauty and personal care brand merchants' revenues were 8.05 billion and 1.805 billion yuan, a year - on - year decrease of 1.3% and an increase of 7.6% respectively. Beauty revenue weakened quarter - on - quarter, while personal care remained flat [18] - Beauty: Affected by the earlier Double Eleven promotion, consumer enthusiasm declined in September, and brands reduced live - streaming activities. In terms of single - quarter revenue growth, Shuiyang Co., Ltd. and Shanghai Jahwa increased by over 20%, Marubi Co., Ltd. had double - digit growth, Proya had low - double - digit decline, and Betaine and Freda had high - single - digit decline [18] - Personal care: Runben Co., Ltd.'s Q3 revenue increased by 17% year - on - year, with a slight increase in growth rate quarter - on - quarter. Baiya Co., Ltd.'s 3Q25 revenue improved, and Dengkang Oral Care had steady growth [18] - In 1 - 3Q25, beauty brand merchants' net profit after non - recurring items was 2.33 billion yuan, a year - on - year decrease of 15%; personal care brand merchants' was 604 million yuan, a year - on - year decrease of 3.4%. Some companies showed initial cost - control effects [24] 3.1.2 Agents - Agents are seeking change in difficult situations by exploring three paths: incubating self - owned brands (represented by Ruoyuchen), using AI to reduce costs and increase efficiency (represented by Yiwow), and expanding high - growth categories (such as Qingmu Technology expanding into trendy toy agency operations) [30] - Ruoyuchen's self - owned brands Feicui and Zhanjia continued to gain momentum. In Q3, self - owned brand revenue was 451 million yuan, a year - on - year increase of 344.5%, accounting for 55.1%. Zhanjia's Q3 revenue was 227 million yuan, a year - on - year increase of 119%, and 1 - 3Q revenue was 680 million yuan. Feicui's Q3 revenue was 203 million yuan, a quarter - on - quarter increase of over 98.8%, and 1 - 3Q revenue was 362 million yuan [30] 3.1.3 Producers - Demand continued to recover, and the revenue of the producer sector increased by 9%, 17%, and 30% year - on - year from Q1 to Q3, with the growth rate increasing quarter by quarter [33] - QingSong Co., Ltd. focused on optimizing customers and product structure, and its profit turned positive for four consecutive quarters from 2Q24 to 1Q25. Jieya Co., Ltd. had increasing orders from overseas big customers, and its Q3 performance growth accelerated. Jiaheng Home Co., Ltd. increased revenue but not profit, mainly due to the short - term impact of the Huzhou base's capacity ramp - up [33] 3.2 Medical Aesthetics: New Entrants with Better - than - Expected Shipments 3.2.1 Upstream Consumables - The growth rate of demand expansion slowed down, and supply - side competition intensified. In terms of the cumulative number of Class III medical device approvals, hyaluronic acid > regenerative (Sculptra/Poly - L - Lactic Acid) > botulinum toxin > recombinant collagen. Old products of hyaluronic acid and regenerative types faced growth pressure, and the growth rate of recombinant collagen Class III medical device products slowed down significantly quarter - on - quarter [38] - Hyaluronic acid: Aimeike's revenue growth rate from 24Q1 to 25Q3 was + 28.2%/+2.3%/+1.1%/ - 7%/ - 18%/ - 25%/ - 21% year - on - year, showing a quarterly decline since 24Q2 [38] - Collagen: Jinbo Biotech's revenue growth rate from 24Q1 to 25Q1 was + 76%/+100%/+92%/+73%/+63% year - on - year, and in 2Q25/3Q25, it was + 30%/+13% year - on - year. On October 23, the "Recombinant Type I α1 Subtype Collagen Freeze - Dried Fiber" Class III medical device certificate of Giant Biogene was approved by NMPA [38] - Leapmed Medical's medical aesthetics shipments were better than expected, with Q3 medical service and health management business revenue of 320 million yuan, a year - on - year increase of 28%, and the revenue of Sculptra and Hydrodermabrasion reaching 86.1367 million yuan [36] 3.2.2 Downstream - The new model of Xinoxygen Medical Clinics showed high - growth potential. The Q3 revenue guidance was 150 - 170 million yuan, a year - on - year increase of 231% - 275%, and a quarter - on - quarter increase of 4% - 18%. It plans to implement the "100 - City, 1000 - Store" plan in the long term [40] - Stores are expanding from first - tier cities to new first - tier and second - tier cities. As of November 6, it covered 42 stores in 10 cities. The promotion of self - owned brands was remarkable, and it cooperated with Xihong Miracle Sculptra 3.0, priced at 2999 yuan, which was officially launched on September 25 [43] 3.3 Investment Recommendations - Brands with upward potential and both growth and certainty: Recommend Maogeping (Oriental aesthetics, dual - wheel drive of makeup and skincare, and the second - curve of perfume is worth looking forward to) and Shangmei Co., Ltd. (with one cornerstone brand, five growth brands, and N seed businesses) [8][46] - Companies with new product pipelines and expected performance elasticity: Pay attention to Giant Biogene and Leapmed Medical [8][46] - Companies in strategic adjustment and expected to reach an inflection point: Recommend Shuiyang Co., Ltd. (the effect of high - end transformation is gradually emerging), and pay attention to Shanghai Jahwa, Betaine, and Freda [8][46]

Core Insights - The article discusses the recent performance and strategic developments of CCM, a company listed under the stock code 02145.HK, highlighting its market position and future outlook [1][2]. Company Overview - CCM has shown significant growth in its revenue, reporting an increase of 15% year-on-year, reaching a total of 1.5 billion in the last fiscal year [1]. - The company has expanded its product offerings, focusing on innovative solutions that cater to emerging market demands [1]. Financial Performance - The net profit margin improved to 20%, up from 17% in the previous year, indicating enhanced operational efficiency [1]. - Total assets have increased to 3 billion, reflecting a robust balance sheet and strong financial health [1]. Market Position - CCM has strengthened its competitive edge by investing in research and development, allocating 10% of its revenue towards innovation [1]. - The company has captured a larger market share, now holding 25% of the industry segment, up from 22% last year [1]. Future Outlook - Analysts predict continued growth for CCM, with expected revenue growth of 12% for the upcoming fiscal year, driven by new product launches and market expansion [1]. - The company is exploring strategic partnerships to enhance its distribution network and increase market penetration [1].

Group 1 - The report highlights the significant achievements in the recent China-US trade talks, with the US agreeing to suspend certain tariffs on Chinese goods, which may positively impact trade dynamics [7] - The macroeconomic policy emphasizes the importance of expanding domestic demand and improving living standards, as outlined in the "15th Five-Year Plan" [5][6] - The report notes a shift in export growth, with October exports showing a decline of 1.1% year-on-year, influenced by high base effects from the previous year [11][12] Group 2 - The report discusses the rebalancing between technology and cyclical sectors, suggesting that both will play significant roles in the market moving forward [17][20] - It identifies the satellite industry as a strategic investment opportunity, driven by large market potential, strong policy support, and technological advancements [23][24] - The report indicates that the REIT market is showing resilience, with the recent listing of the CITIC Construction Investment Shenyang International Software Park REIT, which is expected to attract investment due to its high dividend yield [65][66]

Investment Rating - The industry investment rating is "Positive" (maintained) [1] Core Insights - The introduction of new tax policies for gold is expected to drive market share towards leading brands in the medium to long term. The new tax policy exempts value-added tax for standard gold transactions, which may lead to increased costs for non-investment gold products, ultimately raising retail prices and potentially suppressing consumer demand in the short term. However, this policy is anticipated to regulate the industry and strengthen the competitive advantage of compliant leading brands [5]. - Domestic beauty brands are beginning to establish a presence on video platforms, with significant growth in the social e-commerce sector. The GMV of WeChat mini-programs is expected to exceed 2.5 trillion yuan in 2025, with social e-commerce accounting for over 50% of total transactions. Brands that leverage this platform effectively may maintain competitive advantages [5]. - The report emphasizes the importance of understanding new consumer narratives shaped by younger generations, suggesting a focus on high-quality domestic brands in beauty, gold jewelry, trendy toys, and tea beverages [22]. Summary by Sections Industry Performance - The new consumption sector showed varied performance, with the beauty and personal care sector declining by 3.10%, while the retail index increased by 0.31% during the week of November 3 to November 7, 2025 [8]. Key Industry Data - In September, retail sales for clothing and textiles increased by 4.7%, cosmetics by 8.6%, and gold and silver jewelry by 9.7%. However, beverage retail sales saw a decline of 0.8% [12][16]. Investment Analysis Recommendations - The report recommends focusing on high-quality domestic brands with strong innovation in beauty, such as Mao Ge Ping and Shangmei; leading brands in traditional gold jewelry favored by younger consumers, such as Laopu Gold and Chaohongji; companies with successful IP creation and operation experience in trendy toys, like Pop Mart; and strong tea beverage brands with extensive market coverage, such as Mixue Group and Guming [22].

Core Insights - The retail industry is experiencing a shift from value preservation to emotional value, with a focus on high-growth segments for investment opportunities [5][28] - The report maintains a positive outlook on the retail sector, emphasizing the importance of consumer insights and differentiated product offerings [5][28] Retail Market Overview - The retail index reported a slight increase of 0.31% during the week of November 3 to November 7, 2025, underperforming the Shanghai Composite Index, which rose by 1.08% [7][16] - Year-to-date, the retail index has increased by 4.20%, lagging behind the Shanghai Composite Index's 19.27% growth [16][20] Investment Strategy for 2026 - The investment strategy highlights four main themes: 1. **Gold and Jewelry**: Focus on high-end and fashionable gold segments, with recommendations for brands like Lao Pu Gold and Chao Hong Ji [5][48] 2. **Retail E-commerce**: Emphasize the transformation of offline retail to enhance service and experience, with key players like Yonghui Supermarket and Ai Ying Shi [5][48] 3. **Cosmetics**: Target domestic brands that capture emotional value and innovate on safety ingredients, recommending brands like Juzi Biological and Pechoin [5][49] 4. **Medical Aesthetics**: Focus on differentiated product manufacturers and expanding medical institutions, with recommendations for brands like Ai Mei Ke and Ke Di-B [5][49] Sector Performance - The jewelry sector is undergoing significant changes due to rising gold prices and a decline in traditional wedding markets, leading to the emergence of brands with strong consumer insights [5][29] - The cosmetics sector is seeing a rise in domestic brands leveraging cultural roots and emotional value to capture market share [5][41] Company-Specific Insights - **Chao Hong Ji**: Reported a revenue increase of 28.4% year-on-year for the first three quarters of 2025, with a notable performance in Q3 [54] - **Yonghui Supermarket**: Experienced a revenue decline of 22.2% year-on-year for the first three quarters of 2025, but is undergoing significant transformation [50] - **Juzi Biological**: Achieved a revenue growth of 21.7% year-on-year for the first half of 2025, focusing on collagen products [50]

Core Insights - The company presented at the 2026 strategy meeting, focusing on the main brand Han Shu's category positioning, structural changes, and future expansion directions, along with updates on multiple brand incubations and overseas plans [1] Brand Performance - The main brand Han Shu continues to grow rapidly, with the GMV of the Hongbai Wan Yao product set optimized to below 50% in October, and the annual GMV proportion of secondary products nearing 15% [1] - The company is diversifying its product structure, with men's, personal care, body, and makeup categories accounting for approximately 20% of GMV [1] - Future expansions include new product series for the Hongbai Wan Yao set, continuous exploration of new ingredient additions for secondary products, and promising collaborations in the makeup category [1] Multi-Brand Development - New brands such as Newpage, Juguangbai, Anminyou, and Jifang show strong potential for growth, with Newpage achieving over 100 million GMV in October and aiming for 800-1,000 million for the full year [2] - Juguangbai reached around 30 million GMV in October and has achieved profitability, while Anminyou's GMV approached 40 million with significant profit margin improvements [2] - The company emphasizes maintaining profitability through refined operations and efficient investment flow [2] Organizational Efficiency - The company adopts a strategy of attracting top talent and building a strong organizational culture, which supports the incubation of differentiated multi-brands [3] - A robust self-broadcasting system has been established, with nearly 85% self-broadcasting ratio achieved in 2025, indicating high operational precision [3] - The company possesses a self-owned supply chain that is highly automated, cost-effective, and exhibits significant economies of scale [3] International Expansion - The company is steadily advancing its overseas strategy, with plans to enter the Indonesian market in 2026, leveraging local operations and the brand's competitive pricing and content marketing capabilities [3] - The new spokesperson Wang Jiaer is expected to enhance brand recognition in Southeast Asia [3] Financial Forecast and Valuation - The company maintains its net profit forecasts for 2025-2027 at 1.101 billion, 1.379 billion, and 1.717 billion respectively, with corresponding EPS of 2.77, 3.46, and 4.31 [4] - The company is assigned a target price of 121.67 yuan based on a 32x PE for 2026, reflecting the stable growth of the main brand and validated operational capabilities [4]

Core Viewpoint - Guangdong Marubi Biotechnology Co., Ltd. (hereinafter referred to as "Marubi") has been warned by the Guangdong Securities Regulatory Bureau due to irregularities in financial accounting and management of raised funds, indicating significant internal management shortcomings [1][2]. Financial Irregularities - Marubi's financial accounting issues include inaccurate revenue recognition, incorrect construction project accounting, and erroneous reporting of related accounting items [1]. - The company used raised funds for cash management without proper disclosure of investment returns and related information [1]. - Following the regulatory warning, Marubi's chairman, secretary of the board, and CFO received warning letters from the regulatory authority [1]. Financial Performance - In the first half of 2025, Marubi's adjusted revenue was 1.765 billion yuan, a decrease of 4.5468 million yuan compared to previous adjustments, while the net profit attributable to shareholders was 174 million yuan, down by 11.3297 million yuan [2]. - For Q3 2025, Marubi reported revenue of 686 million yuan, a year-on-year increase of 14.28%, and a net profit of 69.4816 million yuan, up 21.16% [4]. - In the first three quarters of 2025, the company achieved revenue of 2.45 billion yuan, a growth of 25.51%, with a net profit of 244 million yuan, increasing by 2.13% [4]. Market Position and Competition - Marubi's main brand, Marubi, is positioned in the mid-to-high-end market, contributing 2.055 billion yuan to the company's total revenue of 2.97 billion yuan in 2024, accounting for 69.24% [4]. - Compared to competitors like Proya and Shiseido, Marubi faces challenges due to its mid-to-high-end pricing strategy and a smaller market size for eye creams [5]. - The company has been slower in transitioning to online sales channels compared to peers, which may hinder its competitive edge [5]. R&D Investment - In the first half of 2025, Marubi's R&D expenses were 39.9648 million yuan, representing 2.26% of total revenue, which is in line with industry averages but lower than leading competitors [6]. - The company aims to transition to a biotechnology-focused beauty brand, but its current R&D investment does not meet the necessary levels for such a transformation [6]. Future Outlook - The company's future development hinges on rebuilding trust in corporate governance and internal controls, enhancing R&D capabilities, and creating new growth engines to satisfy investors [6].

Group 1: Market Overview - The consumer service, retail, and media sectors in Hong Kong have shown significant performance, with the consumer service sector down by 17.34%, retail up by 94.61%, and media up by 50.98% as of October 24, 2025 [13][10][12] - The strong valuation recovery in Hong Kong stocks is attributed to a combination of global interest rate cuts, inflows of foreign and southbound capital, and the revaluation of core internet assets like Tencent and Alibaba [13][10] - The new consumption leaders in IP toys, tea drinks, and beauty sectors are showing positive fundamentals, leading to structural market trends [13][10] Group 2: IP Economy - The global licensed consumer goods market is projected to reach $307.9 billion in 2024, with a year-on-year growth of 10% [28] - Fashion apparel is identified as the category with the highest growth potential at 70%, followed by toys at 54% and food and beverages at 52% [31] - Disney, Pokémon, and Sanrio are leading in licensed retail sales, with Disney achieving $62 billion in 2024 [29][31] Group 3: Health and Wellness - The ready-to-drink beverage segment is expected to see significant penetration growth globally, with companies like Mixue Group and Guming benefiting from a positive operational cycle [4] - The return of home-cooked meals and increased health awareness are driving demand for traditional and healthy food options [4] Group 4: Beauty Sector - The cosmetics sector in China is experiencing slower growth compared to overall retail, with Douyin (TikTok) emerging as a key player in marketing and sales [4] - New ingredients and concepts are gaining traction, with a rise in oral beauty and health products [4] Group 5: Globalization Trends - The demand for spiritual entertainment in the Middle East is surging, with companies like Red Child City Technology seeing over 60% of their revenue from this region [4] - The cross-border e-commerce landscape is expanding, with companies like J&T Express capitalizing on the growth in Southeast Asia, where parcel volumes increased by 79% year-on-year [4] Group 6: Consumer Behavior Changes - The shift in consumer behavior towards more personalized and experiential consumption is evident, with a focus on self-fulfillment and value realization [4] - The education sector is adapting to changing perceptions, with new products targeting high school and college graduates to address employment challenges [4] Group 7: Entertainment and Leisure - The live music and sports sectors are expected to outperform the broader service consumption market, with companies like Ctrip and Damai Entertainment positioned to benefit [4] - The domestic concert market is maintaining high growth, with ticket sales and attendance showing significant year-on-year increases [73]

Core Viewpoint - Coty Inc., a century-old French perfume giant, is facing significant challenges, including declining performance across all business segments, plans to divest its mass cosmetics division, and the potential loss of the Gucci brand license, which could severely impact its revenue and profitability [1][28]. Financial Performance - For Q1 of fiscal year 2026, Coty's net revenue was $1.577 billion, a decrease of 6% year-over-year, and an 8% decline on a like-for-like basis [2][9]. - The reported net income was $64.6 million, down 19%, with a net profit margin of 4.1% [2][9]. - The mass beauty segment reported an operating loss of $7.7 million, with a loss rate of 1.5%, and an adjusted operating profit margin of 0.3%, down from 4.3% the previous year [9][28]. Business Segment Analysis - The high-end beauty segment generated $1.07 billion in net revenue, accounting for 68% of total sales, with a reported decline of 4% and a like-for-like decline of 6% [6][9]. - The mass beauty segment's net revenue was $508 million, representing 32% of total sales, with a reported decline of 9% and a like-for-like decline of 11% [6][9]. Regional Performance - All three major regions reported declines, with the Asia-Pacific region experiencing the largest drop of 9%, although there are signs of gradual improvement in the Chinese market [10][12]. - The European, Middle Eastern, and African markets, as the largest revenue source, saw a reported decline of 4% and a like-for-like decline of 9% [21][12]. Competitive Landscape - Coty is losing market share in the competitive global beauty landscape, particularly in the high-end fragrance segment, where it faces intense competition from companies like L'Oréal and Estée Lauder [24][28]. - The potential loss of the Gucci Beauty license, which contributes approximately 8% to Coty's sales and 11% to its profits, poses a significant risk to its future as an independent company [28][30]. Strategic Focus - Coty is focusing on optimizing its remaining high-end beauty operations and exploring new partnerships, while also emphasizing its core strength in the fragrance category [29][30]. - The company has appointed a new president for its mass beauty division, indicating a strategic shift aimed at addressing its current challenges [29].